Twenty-nine patients (52.7%) developed colorectal cancer and extra-colonic tumors; the causative gene was MLH1 in 15 patients (48.3%), MSH2 in 10 patients (58.8%), and MSH6 in 4 patients (57.1%). Here, MSH6 is linked to colorectal cancer.